Harvard Medical School - (Peginterferon) Online CME

Harvard Medical School - Online CME
Chronic hepatitis C afflicts 170 million individuals worldwide and is a major cause of morbidity and mortality. We discuss the various modes of acquisition of hepatitis C.

Chronic Hepatitis C: The Road Ahead
Program Chair Willis C. Maddrey, MD Executive Vice President for Clinical Affairs Professor of Internal Medicine The University of Texas Southwestern Medical Center at Dallas

Hepatitis C Top Articles
Individuals with chronic hepatitis C virus (HCV) infection who have failed on the current standard of care (peginterferon alfa plus ribavirin) currently have no viable

Hepatitis C Factsheet - Liver Health Information - The American Liver
However, there is a low prevalence of the infection in long-term spouses of people with chronic hepatitis C virus who have no other risk factor for infection.

VA National Hepatitis C Program
Treatment Recommendations for Patients with Chronic Hepatitis C (version 5, September 2003) Treatment of Patients with Cirrhosis and Portal Hypertension (version 1, October 2003)